Incidence and Survival of Gastro-Entero-Pancreatic Neuroendocrine Neoplasms in the Contemporary Era - Takeaways - MDSpire

Incidence and Survival of Gastro-Entero-Pancreatic Neuroendocrine Neoplasms in the Contemporary Era

  • By

  • Julie Hallet

  • Léamarie Meloche-Dumas

  • Carlotta Sarzo

  • Colin Court

  • Jessica Armah

  • Anna Ding

  • Wing C. Chan

  • Simron Singh

  • June 3, 2026

  • 0 min

Share

  • 1

    Neuroendocrine neoplasms (NENs) are a heterogeneous group of tumors with slower growth and significant variability in presentation.

  • 2

    Gastro-entero-pancreatic NENs (GEP-NENs) have become one of the most prevalent gastrointestinal malignant neoplasms in recent years.

  • 3

    Advancements in diagnosis, classification, and treatment of NENs have improved detection and prognostication over the past two decades.

  • 4

    A retrospective cohort study analyzed the incidence and survival of patients diagnosed with GEP-NENs in Ontario from 2000 to 2023.

  • 5

    Outcomes of interest included incidence rates, overall survival, and cancer-specific survival following GEP-NEN diagnosis.

Original Source(s)

Incidence and Survival of Gastro-Entero-Pancreatic Neuroendocrine Neoplasms in the Contemporary Era

  • by Julie Hallet, Léamarie Meloche-Dumas, Carlotta Sarzo, Colin Court, Jessica Armah, Anna Ding, Wing C. Chan, Simron Singh

  • June 3, 2026

Related Content

Liquid biopsy-guided kidney-sparing management in upper tract urothelial carcinoma: from preoperative risk stratification to perioperative surveillance

Towards ultra-fast treatments: large energy acceptance beam delivery systems and opportunities for proton beam therapy

Clinical benefit of paclitaxel/carboplatin plus bevacizumab with zoledronic acid in pulmonary epithelioid hemangioendothelioma complicated by hypertrophic pulmonary osteoarthropathy and cardiac tamponade: a case report